Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID‐19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID‐19
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-08
DOI
10.1111/bcp.14459
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias
- (2020) Dahai Zhao et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Liver Biochemistries in Hospitalized Patients With COVID‐19
- (2020) Patricia P. Bloom et al. HEPATOLOGY
- Acute Liver Injury in COVID‐19: Prevalence and Association with Clinical Outcomes in a Large US Cohort
- (2020) Meaghan M. Phipps et al. HEPATOLOGY
- Liver injury during highly pathogenic human coronavirus infections
- (2020) Ling Xu et al. LIVER INTERNATIONAL
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: Should we worry?
- (2020) Magdalena Meszaros et al. LIVER INTERNATIONAL
- EASL Clinical Practice Guidelines: Drug-induced liver injury
- (2019) Raúl Andrade et al. JOURNAL OF HEPATOLOGY
- Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
- (2018) E. Raschi et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The role of tocilizumab in the treatment of inflammatory diseases of the eye and orbit: A useful alternative
- (2018) J. Ruiz-Medrano et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia
- (2018) Ana Luisa Oliveira et al. ANNALS OF THE RHEUMATIC DISEASES
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis
- (2017) Mark C. Genovese et al. Arthritis & Rheumatology
- Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System
- (2016) T. Flaig et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
- (2015) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
- (2015) Einar S. Björnsson et al. HEPATOLOGY
- Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
- (2015) Takahiro Hashimoto-Kataoka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical safety of tocilizumab in rheumatoid arthritis
- (2010) Bernard Bannwarth et al. Expert Opinion On Drug Safety
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now